Sort by
Refine Your Search
-
Immunology and Computational Biology Reference number: 2025-0105 We are deploying advanced in vitro and in vivo model systems, genetic perturbations and single cell technologies with spatial readouts to study
-
completed PhD in (bio)informatics or (neuro)immunology A completed Master’s degree in biology, biomedicine, bioinformatics, or data science Basic knowledge in cell culture, immunology, and molecular biology
-
of Cardiovascular Research (DZHK) and the collaborative research center CRC1550 "Molecular Circuits of Heart Disease". Your Profile PhD in molecular biology, epigenetics, cardiovascular science, computational biology
-
(independently and in our team) involvement in teaching across different life science study programs at the Faculty of Medicine Required skills: Ph.D. (or comparable) in Bioinformatics, Computational Biology
-
of Biology and Physics, the Max Planck Institute for Polymer Research, the Max Planck Institute for Chemistry, the Institute for Molecular Biology, and the Mainz University Medical Center. Wilken Lab: Life
-
field Strong publication record and experience in basic science or translational research Background in molecular oncology, tumor biology, liver-focused or immune-focused research, or computational
-
biology, biochemistry, nutritional sciences or another biological/medical field Expertise in chronobiology and circadian rhythms analysis Experience in general molecular and cell biology methods Experience
-
possible date at the KlausTschira Institute for Integrative Computational Cardiology to join our interdisciplinary project at the forefront of RNA biology and sequencing technology. Project Overview
-
species Perform bioinformatics and computational analyses to identify microbiome-lifespan relationships Apply rigorous molecular biology methodologies to elucidate mechanisms underlying microbiome effects
-
researcher (m/f/d) (biology, biochemistry, biotechnology or related areas) Our project investigates the mechanisms of inherited bone marrow failure and its progression into hematological malignancies. Our